| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |